Your browser doesn't support javascript.
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual.
Kernéis, Solen; Planas, Delphine; Imbeaud, Sandrine; Staropoli, Isabelle; Puech, Julien; Robillard, Nicolas; Rodary, Julien; Bruel, Timothée; Vieillard, Thomas; Schwartz, Olivier; Belec, Laurent; Péré, Hélène; Veyer, David.
  • Kernéis S; Equipe de Prévention du Risque Infectieux, AP-HP, Hôpital Bichat, Paris, France.
  • Planas D; Université de Paris, INSERM, IAME, Paris, France.
  • Imbeaud S; Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France.
  • Staropoli I; Vaccine Research Institute, Faculté de Médecine, INSERM U955, Université Paris-Est Créteil , Créteil, France.
  • Puech J; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, INSERM U1138, Paris, France.
  • Robillard N; Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France.
  • Rodary J; Vaccine Research Institute, Faculté de Médecine, INSERM U955, Université Paris-Est Créteil , Créteil, France.
  • Bruel T; Laboratoire de Virologie, Service de Microbiologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Vieillard T; Laboratoire de Virologie, Service de Microbiologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Schwartz O; Laboratoire de Virologie, Service de Microbiologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Belec L; Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France.
  • Péré H; Vaccine Research Institute, Faculté de Médecine, INSERM U955, Université Paris-Est Créteil , Créteil, France.
  • Veyer D; Laboratoire Biosmose-idf, Rueil-Malmaison, France.
Open Forum Infect Dis ; 8(8): ofab369, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1352260
ABSTRACT
Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a confirmed transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of BNT162b2, despite antispike seroconversion.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines / Variants Language: English Journal: Open Forum Infect Dis Year: 2021 Document Type: Article Affiliation country: Ofid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines / Variants Language: English Journal: Open Forum Infect Dis Year: 2021 Document Type: Article Affiliation country: Ofid